Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism

  • B. D. Levy, N. W. Lukacs, A. A. Berlin, B. Schmidt, W. J. Guilford, C. N. Serhan, J. F. Parkinson
  • The FASEB Journal, July 2007, Federation of American Societies For Experimental Biology (FASEB)
  • DOI: 10.1096/fj.07-8653com

The authors haven't yet claimed this publication.

Read Publication